James M. McKenney, PharmD

home / authors / james-m-mckenney-pharmd

Articles

December 1st 2007

Understanding Practice Patterns and Low-density Lipoprotein Cholesterol Goal Attainment Implications of Switching Patients From Simvastatin in a Health Plan Setting

Caroline R. Harley, PhD Sanjay K. Gandhi, PhD Nze Anoka, MS, MBA Michael F. Bullano, PharmD James M. McKenney, PharmD

November 1st 2006

Effectiveness and Cost-effectiveness of Rosuvastatin, Atorvastatin, and Simvastatin Among High-Risk Patients in Usual Clinical Practice

Robert L. Ohsfeldt, PhD Sanjay K. Gandhi, PhD Kathleen M. Fox, PhD, MPH Thomas a. Stacy, PharmD James M. McKenney, PharmD

October 1st 2006

An Assessment of Statin Safety

James M. McKenney, PharmD

July 1st 2002

Statin Pharmacology May Have Important Clinical Implications

James M. McKenney, PharmD

August 1st 2001

Lipid Management: Tools for Getting to the Goal

James M. McKenney, PharmD

November 1st 2000

Introduction: Missing the Target with Lipid-Lowering Therapy

Donald B. Hunninghake, MD James M. McKenney, PharmD

November 1st 2000

Improving Cholesterol Control in Managed Care Populations

James M. McKenney, PharmD

April 1st 1998

Issues and Controversies in Pharmacoeconomics

William F. McGhan, PharmD, PhD James M. McKenney, PharmD Susan Andrade, ScD Sidney C. Smith, Jr, MD Bruce Kinosian, MD Joel W. Hay, PhD

January 1st 1998

Economic Benefits of Aggressive Lipid Lowering: A Managed Care Perspective

James M. McKenney, PharmD Bruce Kinosian, MD

December 1st 1996

Introduction: Creating an Optimal Strategy for Lipid Management

James M. McKenney, PharmD William H. Frishman, MD

Latest Updated Articles

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Jason Porter, MD, an expert on lung cancer

Published: July 24th 2024 | Updated: July 27th 2024

Long-Term Follow-Up from CheckMate 9LA at ASCO 2024

Jason Porter, MD, an expert on lung cancer

Published: July 24th 2024 | Updated: July 27th 2024

Insights from the TROPION-Lung05 Trial at ASCO 2024

Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School

Published: July 24th 2024 | Updated: July 27th 2024

Examining Trends, Future Directions in AI and Health Care

Aspirin tablets dissolving in water | Imaged credit: Victor Moussa - stock.adobe.com

Published: July 15th 2024 | Updated: July 27th 2024

No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD

Alfred L. Garfall, MD, an expert on multiple myeloma

Published: July 24th 2024 | Updated: July 27th 2024

Future Directions in the Management of Multiple Myeloma

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions